Cargando…

EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities

Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypicall...

Descripción completa

Detalles Bibliográficos
Autores principales: Argani, Pedram, Harvey, Isabel, Nielsen, G. Petur, Takano, Angela, Suurmeijer, Albert J. H., Voltaggio, Lysandra, Zhang, Lei, Sung, Yun-Shao, Stenzinger, Albrecht, Mechtersheimer, Gunhild, Dickson, Brendan C., Antonescu, Cristina R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584759/
https://www.ncbi.nlm.nih.gov/pubmed/32770123
http://dx.doi.org/10.1038/s41379-020-0646-5
_version_ 1783599654988939264
author Argani, Pedram
Harvey, Isabel
Nielsen, G. Petur
Takano, Angela
Suurmeijer, Albert J. H.
Voltaggio, Lysandra
Zhang, Lei
Sung, Yun-Shao
Stenzinger, Albrecht
Mechtersheimer, Gunhild
Dickson, Brendan C.
Antonescu, Cristina R.
author_facet Argani, Pedram
Harvey, Isabel
Nielsen, G. Petur
Takano, Angela
Suurmeijer, Albert J. H.
Voltaggio, Lysandra
Zhang, Lei
Sung, Yun-Shao
Stenzinger, Albrecht
Mechtersheimer, Gunhild
Dickson, Brendan C.
Antonescu, Cristina R.
author_sort Argani, Pedram
collection PubMed
description Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypically. One such remarkable example of chromosomal translocation promiscuity is represented by fusions between EWSR1 or FUS with genes encoding for CREB-transcription factors family (ATF1, CREB1 and CREM), driving the pathogenesis of various tumor types spanning mesenchymal, neuroectodermal, and epithelial lineages. In this study we investigate a group of 13 previously unclassified malignant epithelioid neoplasms, frequently showing an epithelial immunophenotype and marked predilection for the peritoneal cavity, defined by EWSR1/FUS-CREB fusions. There were 7 females and 6 males, with a mean age of 36 (range 9–63). All except 3 cases occurred intra-abdominally, including one each involving the pleural cavity, upper and lower limb soft tissue. All tumors showed a predominantly epithelioid morphology associated with cystic or microcystic changes and variable lymphoid cuffing either intermixed or at the periphery. All except one case expressed EMA and/or CK, 5 were positive for WT1, while being negative for melanocytic and other mesothelioma markers. Nine cases were confirmed by various RNA sequencing platforms, while in the remaining 4 cases the gene rearrangements were detected by FISH. Eleven cases showed the presence of CREM-related fusions (EWSR1-CREM, 7; FUS-CREM, 4), while the remaining 2 harbored EWSR1-ATF1 fusion. Clinically, 7 patients presented with and/or developed metastases, confirming a malignant biologic potential. Our findings expand the spectrum of tumors associated with CREB-related fusions, defining a novel malignant epithelioid neoplasm with an immunophenotype suggesting epithelial differentiation. This entity appears to display hybrid features between angiomatoid fibrous histiocytoma (cystic growth, lymphoid cuffing) and mesothelioma (peritoneal/pleural involvement, epithelioid phenotype, and cytokeratin and WT1 co-expression).
format Online
Article
Text
id pubmed-7584759
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-75847592021-02-07 EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities Argani, Pedram Harvey, Isabel Nielsen, G. Petur Takano, Angela Suurmeijer, Albert J. H. Voltaggio, Lysandra Zhang, Lei Sung, Yun-Shao Stenzinger, Albrecht Mechtersheimer, Gunhild Dickson, Brendan C. Antonescu, Cristina R. Mod Pathol Article Gene fusions constitute pivotal driver mutations often encoding aberrant chimeric transcription factors. However, an increasing number of gene fusion events have been shown not to be histotype specific and shared among different tumor types, otherwise completely unrelated clinically or phenotypically. One such remarkable example of chromosomal translocation promiscuity is represented by fusions between EWSR1 or FUS with genes encoding for CREB-transcription factors family (ATF1, CREB1 and CREM), driving the pathogenesis of various tumor types spanning mesenchymal, neuroectodermal, and epithelial lineages. In this study we investigate a group of 13 previously unclassified malignant epithelioid neoplasms, frequently showing an epithelial immunophenotype and marked predilection for the peritoneal cavity, defined by EWSR1/FUS-CREB fusions. There were 7 females and 6 males, with a mean age of 36 (range 9–63). All except 3 cases occurred intra-abdominally, including one each involving the pleural cavity, upper and lower limb soft tissue. All tumors showed a predominantly epithelioid morphology associated with cystic or microcystic changes and variable lymphoid cuffing either intermixed or at the periphery. All except one case expressed EMA and/or CK, 5 were positive for WT1, while being negative for melanocytic and other mesothelioma markers. Nine cases were confirmed by various RNA sequencing platforms, while in the remaining 4 cases the gene rearrangements were detected by FISH. Eleven cases showed the presence of CREM-related fusions (EWSR1-CREM, 7; FUS-CREM, 4), while the remaining 2 harbored EWSR1-ATF1 fusion. Clinically, 7 patients presented with and/or developed metastases, confirming a malignant biologic potential. Our findings expand the spectrum of tumors associated with CREB-related fusions, defining a novel malignant epithelioid neoplasm with an immunophenotype suggesting epithelial differentiation. This entity appears to display hybrid features between angiomatoid fibrous histiocytoma (cystic growth, lymphoid cuffing) and mesothelioma (peritoneal/pleural involvement, epithelioid phenotype, and cytokeratin and WT1 co-expression). 2020-08-07 2020-11 /pmc/articles/PMC7584759/ /pubmed/32770123 http://dx.doi.org/10.1038/s41379-020-0646-5 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Argani, Pedram
Harvey, Isabel
Nielsen, G. Petur
Takano, Angela
Suurmeijer, Albert J. H.
Voltaggio, Lysandra
Zhang, Lei
Sung, Yun-Shao
Stenzinger, Albrecht
Mechtersheimer, Gunhild
Dickson, Brendan C.
Antonescu, Cristina R.
EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
title EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
title_full EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
title_fullStr EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
title_full_unstemmed EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
title_short EWSR1/FUS-CREB Fusions Define a Distinctive Malignant Epithelioid Neoplasm with Predilection for Mesothelial-Lined Cavities
title_sort ewsr1/fus-creb fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584759/
https://www.ncbi.nlm.nih.gov/pubmed/32770123
http://dx.doi.org/10.1038/s41379-020-0646-5
work_keys_str_mv AT arganipedram ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT harveyisabel ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT nielsengpetur ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT takanoangela ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT suurmeijeralbertjh ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT voltaggiolysandra ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT zhanglei ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT sungyunshao ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT stenzingeralbrecht ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT mechtersheimergunhild ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT dicksonbrendanc ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities
AT antonescucristinar ewsr1fuscrebfusionsdefineadistinctivemalignantepithelioidneoplasmwithpredilectionformesotheliallinedcavities